Regenerative Medicine for Joint Hypermobility and Instability

Clinical trial NCT07688096 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07688096
Sponsor: Manhattan Pain Medicine, PLLC
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ehlers-Danlos Syndrome Hypermobility Type (hEDS)Ehlers-Danlos Syndrome (EDS)Joint Hypermobility Joint Instability Hypermobility Spectrum Disorder Chronic Pain Syndrome Musculoskeletal Pain Sprain Subluxation Dislocation Craniocervical Disfunction

Start date: 2026-07-15
Primary completion: 2027-09-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.